http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adaa1e17a27780f08888500df3ebf886
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Daud |
| name | Adil I Daud Adil I. Daud |
| given-name | Adil I. Adil I |
| organization-name | Department of Interdisciplinary Oncology, Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 2Hematology/Oncology Division, University of California at San Francisco, San Francisco, California; and Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee... Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA Department of Dermatology, University of California, San Francisco, CA 94143 Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USA Authors' Affiliations: 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; 2Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio; 3Georgia Cancer Specialists, Atlanta, Georgia; 4University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California; 5Translational Genomics Research Institute and Scottsdale Healthcare, Scottsdale, Arizona; 6Swedish Cancer Institute, Seattle, Washington; 7Indiana University Simon Cancer Center, Indianapolis, Indiana; 8Pfizer Inc, Collegeville, Pennsylvania; 9Pfizer Inc., Cambridge, Massachusetts; 10Pfizer Global Research and Development, Paris, France; 11Pfizer Inc, La Jolla, California; and 12Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Authors' Affiliation: Experimental Therapeutics Program, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida From the H. Lee Moffitt Cancer Center, Tampa, FL; and Mitchell Cancer Institute, University of South Alabama, Mobile, AL Authors' Affiliations: Departments of 1Genitourinary Oncology and 2Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; 3Seattle Cancer Care Alliance, University of Washington, Seattle, Washington; 4MD Anderson Cancer Center, Orlando, Florida; 5University of Colorado Cancer Center, Denver, Colorado; and 6Altor BioScience Corporation, Miramar, Florida Cutaneous Oncology Program, at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; Experimental Therapeutics Program at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida Adil I. Daud, Michelle T. Ashworth, Alan P. Venook, Jennifer A. Grabowsky, and Pamela N. Munster, University of California, San Francisco, San Francisco; Jonathan W. Goldman and Lee S. Rosen, University of California, Los Angeles, Santa Monica, CA; Jonathan Strosberg and Gregory Springett, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Mendelson, Pinnacle Oncology Hematology, Scottsdale, AZ; and Sabine Loechner, Frances Shanahan, David Parry, Stuart Shumway, Tomoko Freshwater,... University of California, 1600 Divisadero St, San Francisco, CA 94143, USA University of California, San Francisco, 1600 Divisadero St, San Francisco, CA 94143, USA H. Lee Moffitt Cancer Center & Research Institute, Cutaneous Oncology and Neurosurgery Program, Tampa, FL 1University of California, San Francisco, San Francisco, California. Departments of Cutaneous Oncology at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 1H. Lee Moffitt Cancer Center, Tampa, Florida and From the Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX; Norton Cotton Cancer Center at the Dartmouth Hitchcock Medical Center, Lebanon, NH; H. Lee Moffitt Cancer Center, Tampa, FL; and Astellas Pharma US Inc, Deerfield IL From the Cutaneous Oncology and Experimental Therapeutics Programs, H. Lee Moffitt Cancer Center; and the Department of Molecular Medicine and Center For Molecular Delivery, College of Medicine, University of South Florida, Tampa, FL Affiliate Research Cutaneous Oncology Program H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida University of California, San Francisco, San Francisco, CA Helen Diller Family Comprehensive Cancer Center University of California San Francisco, San Francisco California Department of Medicine, Hematology/Oncology, University of California, San Francisco |
Incoming Links
Total number of triples: 93.